A

Agenovir Corporation

9 employees

Agenovir is developing novel antiviral therapeutics for diseases associated with viral reservoirs

Basic info

Industry

biotechnology

Sectors

Biotechnology
Medical Device
Health Care
Therapeutics

Date founded

2014

Funding rounds raised

Total raised

$11M

from 3 investors over 3 rounds

A

Agenovir Corporation raised $11M on May 17, 2016

Investors: Lightspeed Venture Partners, Celgene and Data Collective

FAQ